0

Journal Articles

in Substance Abuse/Alcoholism
 1-20 of 246 Articles
Original Article |  May 01, 2013
Polygenic Risk and the Developmental Progression to Heavy, Persistent Smoking and Nicotine Dependence:  Evidence From a 4-Decade Longitudinal Study
Daniel W. Belsky, PhD; Terrie E. Moffitt, PhD; Timothy B. Baker, PhD; et al.
JAMA Psychiatry. 2013;70(5):534-542. doi:10.1001/jamapsychiatry.2013.736.
INCLUDES: , Supplemental Content
Original Article |  May 01, 2013 ONLINE FIRST
A Prospective Assessment of Reports of Drinking to Self-medicate Mood Symptoms With the Incidence and Persistence of Alcohol Dependence
Rosa M. Crum, MD, MHS; Ramin Mojtabai, MD, PhD; Samuel Lazareck, MD, MSc; et al.
JAMA Psychiatry. 2013;():1-9. doi:10.1001/jamapsychiatry.2013.1098.
INCLUDES: , Supplemental Content
Editorial |  May 01, 2013 FREE ONLINE FIRST
Brain Imaging Biomarkers to Predict Relapse in Alcohol Addiction
Nora D. Volkow, MD; Ruben D. Baler, PhD
JAMA Psychiatry. 2013;():1-3. doi:10.1001/jamapsychiatry.2013.1141.
Original Article |  May 01, 2013 FREE ONLINE FIRST
Disrupted Ventromedial Prefrontal Function, Alcohol Craving, and Subsequent Relapse Risk
Dongju Seo, PhD; Cheryl M. Lacadie, BA; Keri Tuit, PsyD; et al.
JAMA Psychiatry. 2013;():1-13. doi:10.1001/jamapsychiatry.2013.762.
INCLUDES: , Supplemental Content
Editorial |  April 10, 2013 ONLINE FIRST
The Potential Value of a Negative Finding:  An Illustrative Example
Kenneth Silverman, PhD; Anthony DeFulio, PhD; Jeannie-Marie Leoutsakos, PhD
JAMA Psychiatry. 2013;():1-2. doi:10.1001/jamapsychiatry.2013.1116.
Original Article |  April 10, 2013 ONLINE FIRST
A Multisite, Double-blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Vigabatrin for Treating Cocaine Dependence
Eugene C. Somoza, MD, PhD; Douglas Winship, BS; Charles W. Gorodetzky, MD, PhD; et al.
JAMA Psychiatry. 2013;():1-8. doi:10.1001/jamapsychiatry.2013.872.
INCLUDES: , Supplemental Content
Original Article |  March 01, 2013
ANKK1, TTC12, and NCAM1 Polymorphisms and Heroin Dependence:  Importance of Considering Drug Exposure
Elliot C. Nelson, MD; Michael T. Lynskey, PhD; Andrew C. Heath, DPhil; et al.
JAMA Psychiatry. 2013;70(3):325-333. doi:10.1001/jamapsychiatry.2013.282.
Original Article |  March 01, 2013
Dose-Related Psychotic Symptoms in Chronic Methamphetamine Users:  Evidence From a Prospective Longitudinal Study
Rebecca McKetin, PhD; Dan I. Lubman, PhD, FRANZCP, FAChAM; Amanda L. Baker, PhD; et al.
JAMA Psychiatry. 2013;70(3):319-324. doi:10.1001/jamapsychiatry.2013.283.
Original Article |  March 01, 2013
Effectiveness of a Selective, Personality-Targeted Prevention Program for Adolescent Alcohol Use and Misuse:  A Cluster Randomized Controlled Trial
Patricia J. Conrod, PhD; Maeve O’Leary-Barrett, BA; Nicola Newton, PhD; et al.
JAMA Psychiatry. 2013;70(3):334-342. doi:10.1001/jamapsychiatry.2013.651.
INCLUDES: , Supplemental Content
Original Article |  February 01, 2013
Within-Family Environmental Transmission of Drug Abuse:  A Swedish National Study
Kenneth S. Kendler, MD; Henrik Ohlsson, PhD; Kristina Sundquist, MD, PhD; et al.
JAMA Psychiatry. 2013;70(2):235-242. doi:10.1001/jamapsychiatry.2013.276.
Original Article |  February 01, 2013
Mapping Common Psychiatric Disorders:  Structure and Predictive Validity in the National Epidemiologic Survey on Alcohol and Related Conditions
Carlos Blanco, MD, PhD; Robert F. Krueger, PhD; Deborah S. Hasin, PhD; et al.
JAMA Psychiatry. 2013;70(2):199-207. doi:10.1001/jamapsychiatry.2013.281.
INCLUDES: , Supplemental Content
Original Article |  February 01, 2013
Macroeconomic Environment During Infancy as a Possible Risk Factor for Adolescent Behavioral Problems
Seethalakshmi Ramanathan, MBBS, DPM; Natarajan Balasubramanian, PhD; Rajeev Krishnadas, MBBS, MRCPsych
JAMA Psychiatry. 2013;70(2):218-225. doi:10.1001/jamapsychiatry.2013.280.
INCLUDES: , Supplemental Content
Original Article |  January 01, 2013
Fecundity of Patients With Schizophrenia, Autism, Bipolar Disorder, Depression, Anorexia Nervosa, or Substance Abuse vs Their Unaffected Siblings
Robert A. Power, BSc; Simon Kyaga, MD; Rudolf Uher, MD, PhD, MRCPsych; et al.
JAMA Psychiatry. 2013;70(1):22-30. doi:10.1001/jamapsychiatry.2013.268.
Original Article |  December 01, 2012
Clinical and Functional Outcome of Childhood Attention-Deficit/Hyperactivity Disorder 33 Years Later
Rachel G. Klein, PhD; Salvatore Mannuzza, PhD; María A. Ramos Olazagasti, PhD; et al.
Arch Gen Psychiatry. 2012;69(12):1295-1303. doi:10.1001/archgenpsychiatry.2012.271.
Original Article |  December 01, 2012
Birth Cohort Effects on Adolescent Alcohol Use:  The Influence of Social Norms From 1976 to 2007
Katherine M. Keyes, PhD; John E. Schulenberg, PhD; Patrick M. O’Malley, PhD; et al.
Arch Gen Psychiatry. 2012;69(12):1304-1313. doi:10.1001/archgenpsychiatry.2012.787.
INCLUDES: , Supplemental Content
Original Article |  November 01, 2012
Familial Confounding of the Association Between Maternal Smoking During Pregnancy and Offspring Substance Use and Problems
Brian M. D’Onofrio, PhD; Martin E. Rickert, MSc, PhD; Niklas Langström, PhD; et al.
Arch Gen Psychiatry. 2012;69(11):1140-1150. doi:10.1001/archgenpsychiatry.2011.2107.
Original Article |  November 01, 2012
Childhood Adversities and First Onset of Psychiatric Disorders in a National Sample of US Adolescents
Katie A. McLaughlin, PhD; Jennifer Greif Green, PhD; Michael J. Gruber, MS; et al.
Arch Gen Psychiatry. 2012;69(11):1151-1160. doi:10.1001/archgenpsychiatry.2011.2277.
Original Article |  November 01, 2012
Predictors of Prospectively Examined Suicide Attempts Among Youth With Bipolar Disorder
Tina R. Goldstein, PhD; Wonho Ha, PhD; David A. Axelson, MD; et al.
Arch Gen Psychiatry. 2012;69(11):1113-1122. doi:10.1001/archgenpsychiatry.2012.650.
Original Article |  October 01, 2012
Prevalence and Persistence of Psychiatric Disorders in Youth After Detention:  A Prospective Longitudinal Study
Linda A. Teplin, PhD; Leah J. Welty, PhD; Karen M. Abram, PhD; et al.
Arch Gen Psychiatry. 2012;69(10):1031-1043. doi:10.1001/archgenpsychiatry.2011.2062.
INCLUDES: , Supplemental Content
Original Article |  September 01, 2012
Randomized Trial of Long-Acting Sustained-Release Naltrexone Implant vs Oral Naltrexone or Placebo for Preventing Relapse to Opioid Dependence
Evgeny Krupitsky, MD, PhD, DMedSci; Edwin Zvartau, MD, PhD, DMedSci; Elena Blokhina, MD, PhD; et al.
Arch Gen Psychiatry. 2012;69(9):973-981. doi:10.1001/archgenpsychiatry.2012.1a.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
JAMA Patient Page  |  May 15, 2013
Misuse of Opioid Medication
Daniel P. Alford, MD, MPH; Edward H. Livingston, MD
JAMA
Viewpoint  |  May 9, 2013
Opioid Analgesics—Risky Drugs, Not Risky Patients
Deborah Dowell, MD, MPH; Hillary V. Kunins, MD, MPH, MS; Thomas A. Farley, MD, MPH
JAMA
Original Contribution  |  May 01, 2013
Association of OPRM1 and COMT Single-Nucleotide Polymorphisms With Hospital Length of Stay and Treatment of Neonatal Abstinence Syndrome
Elisha M. Wachman, MD; Marie J. Hayes, PhD; Mark S. Brown, MD, MSPH; et al.
JAMA
Viewpoint  |  February 25, 2013
DSM-5 —The Future Arrived
David J. Kupfer, MD; Emily A. Kuhl, PhD; Darrel A. Regier, MD, MPH
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems